Concepedia

Aggressive silent corticotroph adenoma progressing to pituitary carcinoma. The role of temozolomide therapy

Olga Moshkin, Luis V. Syro, Bernd W. Scheithauer, León Darío Ortiz, Camilo E. Fadul, Humberto Uribe, Ricardo R. González, Michael D. Cusimano, Éva Horváth, Fabio Rotondo,

HORMONES · 2011 · 57 citations · 20 references

DOIFull text

Open access

Concepts

References

20

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.3K citations · Full text

, , +17

Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors

Sara Ekeblad, Anders Sundin, Eva Tiensuu Janson et al. · Clinical Cancer Research · 2007 · 476 citations · Full text

, , +13

MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma

Anurag Verma · Yearbook of Neurology and Neurosurgery · 2006 · 466 citations

, , +14

Temozolomide: a novel treatment for pituitary carcinoma

Stephen Lim, Hrayr K. Shahinian, Menahem M. Maya et al. · The Lancet Oncology · 2006 · 179 citations

, , +9

Long-term response of pituitary carcinoma to temozolomide

Camilo E. Fadul, Andrew L. Kominsky, Louise P. Meyer et al. · Journal of neurosurgery · 2006 · 165 citations

, , +13